Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$13.72 - $51.57 $848,527 - $3.19 Million
-61,846 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$10.54 - $18.47 $333,127 - $583,762
31,606 Added 104.52%
61,846 $1.09 Million
Q2 2020

Aug 17, 2020

BUY
$10.37 - $20.64 $313,588 - $624,153
30,240 New
30,240 $551,000
Q3 2019

Nov 14, 2019

SELL
$8.95 - $15.72 $159,041 - $279,344
-17,770 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$14.61 - $22.45 $259,619 - $398,936
17,770 New
17,770 $282,000

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $2.17B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.